Skip to content
Menu

BTIG Maintains Buy on Medtronic, Raises Price Target to $109

Benzinga Newsdesk 3 days ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $99 to $109.

BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $99 to $109.

Read at benzinga.com

← All stock news